Lyska L. Emerson
No Rating Available
(Learn About Our Rating System)

Lyska L. Emerson, MD

Languages spoken: English

  • Dr. Emerson's service work is predominantly in general surgical pathology with a subspecialty interest in pulmonary pathology. Her research efforts are currently in the area of lung cancer genomics.

    Specialties

    • Pulmonary Pathology
    • Surgical Pathology
    • Pathology, Anatomical

    Board Certification

    American Board of Pathology (Anatomic)

  • Dr. Emerson's service work is predominantly in general surgical pathology with a subspecialty interest in pulmonary pathology. Her research efforts are currently in the area of lung cancer genomics.

    Board Certification and Academic Information

    Academic Departments Pathology -Professor (Clinical)
    Board Certification
    American Board of Pathology (Anatomic)

    Education history

    Undergraduate Science - Baylor University B.S.
    Professional Medical Medicine - University of Texas Health Science Center at Houston M.D.
    Residency Pathology - University of New Mexico Health Sciences Center Resident
    Residency Pathology - University of Texas Health Science Center at Houston Resident
    Fellowship Surgical Pathology - University of Utah School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Fang WS, Emerson LL, Hunt JP, Salzman KL (2009). An unusual sinonasal tumor: soft tissue perineurioma. AJNR Am J Neuroradiol, 30(2), 437-9. (Read full publication)
    2. Emerson LL, Tripp SR, Baird BC, Layfield LJ, Rohr LR (2006). A comparison of immunohistochemical stain quality in conventional and rapid microwave processed tissues. Am J Clin Pathol, 125(2), 176-83. (Read full publication)
    3. Feng Y, Emerson L, Jeong EK, Parker DL, Lu ZR (2009). Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy. J Magn Reson Imaging, 30(2), 401-6. (Read full publication)
    4. Poruk KE, Firpo MA, Huerter LM, Scaife CL, Emerson LL, Boucher KM, Jones KA, Mulvihill SJ (2010). Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 19(10), 2605-10. (Read full publication)
    5. Tanaka R, Emerson LL, Karwande SV, Schreiber (2005). Growing pulmonary nodule with increased 18-fluorodeoxyglucose uptake in a former smoker. Chest, 127(5), 1848-51. (Read full publication)
    6. Peterson KA, Thomas KL, Hilden K, Emerson LL, Wills JC, Fang J (2010). Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Digestive diseases and sciences, 55(5), 1313-9. (Read full publication)
    7. Rowe LR, Mulvihill SJ, Emerson L, Gopez E (2007). Subcutaneous tumor seeding following needle core biopsy of hepatocellular carcinoma. Diagnostic cytopathology, 35(11), 717-21. (Read full publication)
    8. Goulet CJ, Disario JA, Emerson L, Hilden K, Holubkov R, Fang J (2007). In vivo evaluation of argon plasma coagulation in a porcine model. Gastrointestinal endoscopy, 65(3), 457-62. (Read full publication)
    9. Alkhatib AA, Craig R, Tuteja AK, Emerson L (2010). Progression of solitary rectal ulcer syndrome over a 2-year period. Gastrointestinal endoscopy, 72(4), 853-4. (Read full publication)
    10. Yu M., Miller ME, Emerson L, Bentz BG, Clayton F, Data RE, Salzman KL, and Smith L (2007). An Unusual case of an extraosseus ewing's sarcoma. Journal of clinical oncology, 25(30), 4845-8.
    11. Dasgupta A, Emerson (1998). Neutralization of cardiac toxins oleandrin, oleandrigenin, bufalin, and cinobufotalin by digibind: monitoring the effect by measuring free digitoxin concentrations. Life sciences, 63(9), 781-8. (Read full publication)
    12. Mohs AM, Nguyen T, Jeong EK, Feng Y, Emerson L, Zong Y, Parker DL, Lu Z (2007). Modification of Gd-DTPA cystine copolymers with PEG-1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography. Magnetic resonance in medicine, 58(1), 110-8. (Read full publication)
    13. Feng Y, Jeong EK, Mohs AM, Emerson L, Lu Z (2008). Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice. Magnetic resonance in medicine, 60(6), 1347-52. (Read full publication)
    14. Goldfarb-Rumyantzev AS, Shihab F, Emerson L, Mineau G, Schaefer C, Tang H, Hunter C, Naiman N, Smith L, Kerber (2009). A population-based assessment of the familial component of acute kidney allograft rejection. Nephrology, dialysis, transplantation, 24(8), 2575-83. (Read full publication)
    15. Emerson LL, Layfield L (2012). Solitary peripheral pulmonary papilloma evaluation on frozen section: a potential pitfall for the pathologist. Pathology, research and practice, 208(12), 726-9. (Read full publication)
    16. Vaidya A, Sun Y, Feng Y, Emerson L, Jeong EK, Lu Z (2008). Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate. Pharmaceutical research, 25(9), 2002-11. (Read full publication)
    17. Wu X, Feng Y, Jeong EK, Emerson L, Lu Z (2009). Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice. Pharmaceutical research, 26(9), 2202-8. (Read full publication)
    18. Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Boucher KM, Mulvihill S (2013). Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas, 42(2), 193-7. (Read full publication)
    19. Emerson L, Layfield L, Reiss R, Mulvihill (2001). Malignant Islet Cell Tumor with Sarcomatous Differentiation. Modern pathology, 14(11), 1187-91.
    20. Wallander ML, Layfield LJ, Emerson LL, Mamalis N, Davis D, Tripp SR, Holden J (2011). KIT mutations in ocular melanoma: frequency and anatomic distribution. Modern pathology, 24(8), 1031-5. (Read full publication)
    21. De La O JP, Emerson LL, Goodman JL, Froebe SC, Illum BE, Curtis AB, Murtaugh L (2008). Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proceedings of the National Academy of Sciences of the United States of America, 105(48), 18907-12. (Read full publication)
    22. Dasgupta A, Emerson (1996). Interaction of valproic acid with nonsteroidal antiinflammatory drugs mefenamic acid and fenoprofen in normal and uremic sera: lack of interaction in uremic sera due to the presence of endogenous factors. Therapeutic drug monitoring, 18(6), 654-9. (Read full publication)
    23. Cowman SJ, Fuja DG, Liu XD, Tidwell RSS, Kandula N, Sirohi D, Agarwal AM, Emerson LL, Tripp SR, Mohlman JS, Stonhill M, Garcia G, Conley CJ, Olalde AA, Sargis T, Ramirez-Torres A, Karam JA, Wood CG, Sircar K, Tamboli P, Boucher K, Maughan B, Spike BT, Ho TH, Agarwal N, Jonasch E, Koh M (2020). Macrophage HIF-1¿ Is an Independent Prognostic Indicator in Kidney Cancer. Clinical cancer research, 26(18), 4970-4982. (Read full publication)
    24. Rollins MD, Sudarshan S, Firpo MA, Etherington BH, Hart BJ, Jackson HH, Jackson JD, Emerson LL, Yang DT, Mulvihill SJ, Glasgow R (2006). Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. Journal of gastrointestinal surgery, 10(8), 1120-30. (Read full publication)
    25. Emerson LL, Carney HM, Layfield LJ, Sherbotie J (2008). Collecting duct carcinoma arising in association with BK nephropathy post-transplantation in a pediatric patient. A case report with immunohistochemical and in situ hybridization study. Pediatric transplantation, 12(5), 600-5. (Read full publication)
    26. Wallander M, Layfield LJ, Jarboe E, Emerson L, Liu T, Thaker H, Holden J, Tripp (2010). Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts. Applied immunohistochemistry & molecular morphology, 18(3), 231-5. (Read full publication)
    27. Zhang X, Bohner A, Bhuvanagiri S, Uehara H, Upadhyay AK, Emerson LL, Bondalapati S, Muddana SK, Fang D, Li M, Sandhu Z, Hussain A, Carroll LS, Tiem M, Archer B, Kompella U, Patil R, Ambati B (2017). Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment. Molecular therapy, 25(7), 1606-1615. (Read full publication)
    28. Corean J, Furtado LV, Kadri S, Segal JP, Emerson L (2019). Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis. International journal of surgical pathology, 27(3), 294-304. (Read full publication)
    29. Boylan KE, Larsen BT, Young BA, Downs-Kelly E, Panchabhai TS, Collum ES, Jensen L, Emerson L (2018). Pulmonary Mycobacterial Spindle Cell Pseudotumor: A Report of 3 Cases Including a Practical Approach to Histopathologic Recognition of This Unusual Entity. International journal of surgical pathology, 26(7), 629-634. (Read full publication)
    30. Goldfarb-Rumyantzev AS, Wright S, Ragasa R, Ostler D, Van Orden J, Smith L, Efimova E, Emerson L, Sandhu GS, Shihab (2011). Factors associated with nonadherence to medication in kidney transplant recipients. Nephron. Clinical practice, 117(1), c33-9. (Read full publication)
    31. Wu X, Jeong E.K., Emerson L, Hoffman J, Parker D.L., Lu Z.R (2010). Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers. Molecular pharmaceutics, 7(1), 41-8.
    32. Kulke MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, Clark OH, Doherty GM, Eason J, Emerson L, Engstrom PF, Goldner WS, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW, Moley JF, Pillarisetty VG, Saltz L, Schteingart DE, Shah MH, Shibata S, Strosberg JR, Vauthey JN, White R, Yao JC, Freedman-Cass DA, Dwyer M (2012). National Comprehensive Cancer Networks. Journal of the National Comprehensive Cancer Network, 10(6), 724-64.
    33. Cook GW, Benton MG, Akerley W, Mayhew GF, Moehlenkamp C, Raterman D, Burgess DL, Rowell WJ, Lambert C, Eng K, Gu J, Baybayan P, Fussell JT, Herbold HD, O'Shea JM, Varghese TK, Emerson L (2020). Structural variation and its potential impact on genome instability: Novel discoveries in the EGFR landscape by long-read sequencing. PloS one, 15(1), e0226340. (Read full publication)
    34. Keefe AC, Hymas JC, Emerson LL, Ryan J (2017). An atypical presentation of cardiac tamponade and periorbital swelling in a patient with eosinophilic granulomatosis with polyangiitis: a case report. Journal of medical case reports, 11(1), 271. (Read full publication)
    35. Scaife CL, Shea J, Emerson L, Boucher K, Firpo MA, Beckerle MC, Mulvihill S (2010). Prognostic significance of PINCH signalling in human pancreatic ductal adenocarcinoma. HPB, 12(5), 352-8. (Read full publication)
    36. Layfield LJ, Emerson L, Crim JR, Randall (2008). Squamous differentiation and cytokeratin expression in an osteosarcoma: a case report and review of the literature. Clinical medicine. Pathology, 1, 55-9. (Read full publication)
    37. Schwartz JL, Woods B, Emerson L, Andtbacka (2009). Appendiceal adenocarcinoma arising after bone marrow transplantation for Non-Hodgkin Lymphoma: an unusual treatment dilemma. (6), 1.
    38. Zitnay RG, Herron MR, Carney KR, Potter S, Emerson LL, Weiss JA, Mendoza M (2022). Mechanics of lung cancer: A finite element model shows strain amplification during early tumorigenesis. PLoS computational biology, 18(10), e1010153. (Read full publication)
    39. Samson SC, Rojas A, Zitnay RG, Carney KR, Hettinga W, Schaelling MC, Sicard D, Zhang W, Gilbert-Ross M, Dy GK, Cavnar MJ, Furqan M, Browning RF Jr, Naqash AR, Schneider BP, Tarhini A, Tschumperlin DJ, Venosa A, Marcus AI, Emerson LL, Spike BT, Knudsen BS, Mendoza M (2024). Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin ¿vß1 and FAK. bioRxiv, (Read full publication)
    40. Sircy LM, Ramstead AG, Gibbs LC, Joshi H, Baessler A, Mena I, García-Sastre A, Emerson LL, Fairfax KC, Williams MA, Hale J (2024). Generation of antigen-specific memory CD4 T cells by heterologous immunization enhances the magnitude of the germinal center response upon influenza infection. PLoS pathogens, 20(9), e1011639. (Read full publication)
    41. Gautam D, Morrison DE, Bounajem MT, Emerson LL, Grandhi (2025). Intraprocedural Thromboembolism From Infective Endocarditis With Immediate Endovascular Mechanical Thrombectomy: A Case of Remarkable Timing. Cureus, 17(2), e78694. (Read full publication)
    42. Scarpato BM, McDonald J, Bayrak-Toydemir P, Elliott CG, Cahill BC, Emerson LL, Keenan L (2023). The Shunt of It. Chest, 163(5), e201-e205. (Read full publication)

    Case Report

    1. Abou-Al-Shaar H, Gozal YM, Hunt JP, Shelton C, Emerson LL, Joyce E, Couldwell W (2018). Multifocal cavernous hemangioma of the jugular foramen: a rare skull base vascular malformation. Journal of neurosurgery, 131(1), 109-113. (Read full publication)
    2. Cirulis MM, Emerson LL, Bull DA, Hatton N, Nativi-Nicolai J, Hildebrandt GC, Ryan J (2016). Pulmonary arterial hypertension in primary amyloidosis. Pulmonary circulation, 6(2), 244-8. (Read full publication)

    Letter

    1. Emerson LL, Layfield LJ, Frame (2007). Pleomorphic olfactory neuroblastoma (esthesioneuroblastoma): histopathological findings and clinical course. Histopathology, 51(3), 430-2. (Read full publication)

    Abstract

    1. Rollins MD, Jackson HH, Emerson LL, Mulvihil SJ, Firpo MA, Glasgow R (2003). Peroxisome proliferator-activated receptor-gamma agonists decrease the severity of acute pancreatitis. Awarded best basic science presentation.
    2. Goulet CJ, Fang JC, Emerson L, Disario J (2004). In Vitro Evaluation of Different Modes of Argon Plasma Coagulation in a Porcine Colon.
    3. Jones RG, Peterson KA, Emerson L (2004). Unusual Gastric Mass.
    4. Feng Y, Jeong EK, Mohs AM, Emerson L, Lu Z (2005). Polydisulfide-based biodegradable macromolecular contrast agents for dynamic contrast enhanced MRI: first experience with human prostate cancer xenograft.
    5. Fang JC, Emerson LL, Hilden K, Thomas KL, Peterson K (2007). Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.
    6. Stafforini DM, Reichert E, Gardner A, Meikle W, Emerson (2007). Deletion of platelet-activating factor acetylhydrolase (phospholipase A2 Group VII) increases the severity of prostate cancer and reduces life-span in the TRAMP model of prostate carcinogenesis.
    7. Feng Y, Jeong EK, Emerson L, Lu Z (2008). Assess tumor acute response to photothermal therapies by DCE-MRI using biodegradable macromolecule contrast agent.
    8. Majer M, Gray P, Li X, Emerson LL, Kuwada S (2008). Conditional deletion of Erbb2/Neu inhibits pancreatic tumorigenesis.
    9. Shea JE, Emerson LL, Scaife C (2009). Metastatic tumors express greater levels of pinch.
    10. Naiman N, Kerber R, Emerson L, Goldfarb A, Tang H, Smith L, Ostler D, Mineau G, Schaefer C, Shihab (2009). A population-based assessment of the familial component of acute kidney allograft rejection.
    11. Firpo MA, Shea JE, Brown K, Emerson L, Boucher KM, Scaife CL, Mulvihill S (2011). Serum MMP-7 is an Independent Predictor of Survival in Patients with Pancreatic Adenocarcinoma. Eleventh Annual Americas Hepato-Pancreato-Biliary Congress, Miami Beach, FL. 13(Suppl 1), 21.
    12. Fang JC, Hilden K, Gleich G, Emerson L (2011). A Pilot Study of the Treatment of Eosinophilic Esophagitis with Omalizumab, Digestive Disease Week, Chicago, IL, May 7-10, 2011.
    13. Poruk KE, Scaife CL, Emerson LL, Boucher KM, Firpo MA, Mulvihill S (2010). Serum platelet factor 4 is an independent predictor of survival in patients with pancreatic adenocarcinoma. American Surgical Congress, San Antonio, TX. Feb 3-5, 2010.
    14. Hewitt K, Shea J, Johnston WC, Emerson L, Scaife (2013). PINCH Expression in Pancreatic Neuroendocrine Tumors. 47th Annual Pancreas Club Meeting, Orlando, FL. May 17-18, 2013.
    15. Wallander ML, Layfield LJ, Emerson LL, Mamalis N, Davis D, Holden J (2011). KIT Mutations in Ocular Melanoma. USCAP, San Antonio, TX, February 26 - March 4, 2011.
    16. Farkash E, Brousaides N, Nickeleit V, Papadimitriou J, Roberts IS, Emerson L, Pelle TD, McDaid J, Colvin (2014). T Antigen Dependent Oncogenic Pathways are Active in Post-Transplant Tumors Driven by BK Polyoma Virus. 2014 World Transplant Congress, San Francisco, CA, Jul 26-31, 2014.

    Other

    1. Layfield L, Emerson (2002). Spindle Cell Predominant Malignant Neuroepithelial Tumor of Kidney.
    2. Emerson L, Chadwick B (2008). Cytologic diagnosis of lymphoid lesions of the thyroid gland.
    3. Layfield L, Gopez E, Emerson (2002). Mediastinal Hemangiolymphangioma: Fine-Needle Aspiration Findings in a Rare Mediastinal Tumor.

  • News & Podcasts

    Huntsman Cancer Institute News